Answers are grounded in this paper and cite their sources.
The identification in craniosynostosis syndromes of mutations in genes belonging to the fibroblast growth factor signalling pathway and the transcriptional regulator MSX2 provides important clues to the pathogenesis of these disorders. Although surgery continues to be the mainstay of treatment, new animal models and improved uncerstanding of cranial suture biology and pathology may lead to complementary therapies.
No takes yet. Share an insight, caveat, or question.
Wilkie et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: